Season 2 - Ep. 12 | Risk-taking and Dealmaking with Global MedTech Leader, Kevin Lobo

Redefiners Podcast
Hosted By:
July 13, 2022 | 36 min
kevin-lobo.jpg
kevin-lobo.jpg
Our guest
Kevin A. Lobo, Chair and CEO, Stryker

Season 2 - Ep. 12 | Risk-taking and Dealmaking with Global MedTech Leader, Kevin Lobo

Take risks, keep learning, and stay calm. It’s how our guest, Stryker Chair and CEO Kevin Lobo, became arguably one of the most successful CEOs ever. We’ll talk with the Indian-born, Canadian-raised, internationally acclaimed businessperson about how he became known as the “Godfather of MedTech” and as an acquisitions deal maker. We’ll hear how Kevin’s high threshold for risk helped Stryker drastically outpace the competition and how he built his Board’s trust to make more than 55 acquisitions. Kevin also shares his insights on timely topics leaders in all industries are talking about: technology, crisis management, company culture, and how to keep employees happy, purpose-driven, and loyal.

If you liked this episode, check out these other Redefiner episodes:

 

Kevin A. Lobo
Chair and CEO, Stryker

Kevin A. Lobo has been CEO of Stryker since October 1, 2012, and also assumed the role of Chair of the Board on July 22, 2014. He joined Stryker in 2011 and had previously been Group President of Orthopaedics.

Mr. Lobo serves on the board of directors for Parker Hannifin Corporation (NYSE:PH), the Advanced Medical Technology Association (AdvaMed) and the U.S.-India Business Council. He is also a member of the Business Roundtable and Business Council.

Mr. Lobo has a broad business career across multiple industries. After holding finance positions with KPMG, Unilever and Kraft Canada, he spent eight years with Rhone-Poulenc, including roles based in Europe as Corporate Controller of a chemical spin-out and General Manager of Specialty Phosphates EMEA. He then spent eight years at Johnson & Johnson, including President of Ethicon Endo Surgery.

 

Listen on


Podcast transcript coming soon.

Read more Read less